CERUS CORP (CERS)
Surgical & Medical Instruments & Apparatus
Latest Price
$2.15
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.35
P/B Ratio
6.18
Valuation metrics
adjust assumptions →Base FCF: $5M (median of recent 5yr)
Growth: -15%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$0.21
90% downside
Institutional Ownership
71.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 21.58M | $39.0M | 11.11% | -343.5K | 2026-03-31 |
| ARK Investment Management LLC | 19.16M | $34.0M | 9.87% | +960.9K | 2026-03-31 |
| Soleus Capital Management, L.P. | 10.75M | $19.0M | 5.54% | +6.75M | 2026-03-31 |
| BAKER BROS. ADVISORS LP | 10.01M | $18.0M | 5.16% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 8.13M | $14.0M | 4.19% | -- | 2026-03-31 |
| WASATCH ADVISORS LP | 5.28M | $9.0M | 2.72% | -181.5K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 4.64M | $8.0M | 2.39% | +147.7K | 2026-03-31 |
| Sumitomo Mitsui Trust Group, Inc. | 4.52M | $8.0M | 2.33% | -193.4K | 2026-03-31 |
| Silvercrest Asset Management Group LLC | 4.24M | $7.0M | 2.18% | -444.4K | 2026-03-31 |
| STATE STREET CORP | 4.21M | $7.0M | 2.17% | +370.0K | 2026-03-31 |